Go Back

AliveCor® to Showcase the AliveCor Heart Monitor at the American Heart

SAN FRANCISCO, Calif. and Chicago, Ill. November 16, 2014 (Booth #932)

Association Scientific Sessions

SAN FRANCISCO, Calif. and Chicago, Ill. November 16, 2014 (Booth #932)AliveCor, Inc. announced today its attendance at the American Heart Association Scientific Sessions taking place at McCormick Place in Chicago, Ill. from November 15-19. There will be many opportunities to learn more about the AliveCor Heart Monitor at the conference, including:

  • In-booth presentations and product demonstrations: AliveCor will offer in-booth presentations and product demonstrations on the clinical capabilities of the AliveCor® Heart Monitor and the AliveECG app.
  • Atrial Fibrillation (AF) Detector: Learn more about AliveCor’s new FDA-cleared automated analysis process (algorithm) that instantly detects if patients are experiencing AF through real-time electrocardiogram (ECG) recordings taken on the AliveCor Heart Monitor, so intervention can take place before potentially life-threatening conditions, like strokes, occur.
  • Provider Dashboard: For health professionals with patients using the AliveCor Heart Monitor, we offer the Provider Dashboard, a free web-based application to help review patients’ ECG data. Demos of the dashboard will be available at our booth.
  • Special Discount: During ACC all AliveCor Heart Monitors will be on sale at our booth for a deeply discounted show price.
  • Discuss our Clinical Studies:
    • A study published in the June 2014 issue of Thrombosis and Haemostasis demonstrated feasibility and cost effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies: *Nicole Lowres et al. Thrombosis and Haemostasis 2014: 111/6 (June) pp. 1007–1199 *
    • A study published in the May 2014 issue of Australian Family Physician reported findings on iPhone screening by practice nurses and receptionists for atrial fibrillation in general practice: the GP-SEARCH qualitative pilot study: Jessica Orchard et al. Australian Family Physician Volume 43, No.5, May 2014.

Follow the AliveCor Twitter handle, @AliveCor, for real-time updates from the ACC show floor. To schedule a briefing with AliveCor, please contact Rebecca Phillips, rebecca@alivecor.com.

The AliveCor Heart Monitor’s medical grade ECG recordings can also be shared directly with a physician, or sent to a U.S. board-certified cardiologist or a U.S-based cardiac technician through a cloud-based ECG analysis service provided by AliveCor. In as little as 30 minutes users can receive expert reviews of their ECGs directly through the AliveECG app providing a more complete picture of their current heart health.

The AliveCor Heart Monitor can be purchased at www.alivecor.com.

Most Recent

July 9, 2024

Introduction of AliveCor's revolutionary InstantQT® solution set to streamline ECG evaluation and enhance patient safety across Europe

Read More

June 25, 2024

AliveCor Announces Dual FDA Clearance of AI Technology That Delivers 35 Cardiac Determinations and First-of-its-Kind Kardia 12L ECG System

Read More

June 5, 2024

AliveCor’s AI-backed ECG Offerings Featured in New Film Series on Innovative Technologies Presented by the Consumer Technology Association

Read More

Let's transform cardiovascular care together

If you are an employer or payer looking for a comprehensive heart health enterprise solution, contact us.